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Persistent organic pollutants have not been conclusively associated with length of gestation or with preterm birth.
Chlordecone is an organochlorine pesticide that has been extensively used to control the banana root borer
population in the French West Indies. Data from the Timoun Mother–Child Cohort Study conducted in Guadeloupe
between 2004 and 2007 were used to examine the associations of chlordecone concentrations in maternal plasma
with the length of gestation and the rate preterm birth in 818 pregnant women. Data were analyzed using multivar-
iate linear regression for length of gestation and a Cox model for preterm birth. The median plasma chlordecone
concentration was 0.39 μg/L (interquartile range, 0.18–0.83). No correlation was observed with plasma concentra-
tions of p,p0-dichlorodiphenyl dichloroethene (ρ = 0.017) or polychlorinated biphenyl 153 (ρ = −0.016), the other
main organochlorine compounds detected. A 1-log10 increase in chlordecone concentration was associated with
a decreased length of gestation (−0.27 weeks; 95% confidence interval: −0.50, −0.03) and an increased risk of
preterm birth (60%; 95% confidence interval: 10, 130). These associations may result from the estrogen-like and
progestin-like properties of chlordecone. These results are of public health relevance because of the prolonged per-
sistence of chlordecone in the environment and the high background rate of preterm births in this population.
chlordecone; French West Indies; length of gestation; persistent organic pollutants; pesticides; preterm birth
Abbreviations: DDE, p,p0-dichlorodiphenyl dichloroethene; LOD, limit of detection.
Editor’s note: An invited commentary on this article
appears on page 545, and the authors’ response appears
on page 548.
Organochlorines are manmade chemicals that are persist-
ent and are still present in the environment despite no longer
being used. These chemicals are considered to pose a threat to
human health, particularly during periods of increased sen-
sitivity, such as gestation (1, 2). A number of studies have
shown associations between maternal or cord blood concen-
trations of p,p0-dichlorodiphenyl dichloroethene (DDE), the
main metabolite of dichlorodiphenyl trichloroethane, and
decreased duration of gestation and/or increased risk of pre-
term birth. The largest study conducted to date included
2,380 children from an early pregnancy cohort set up in the
United States in the 1960s, and it showed a dose-response
relationship between the maternal blood concentration of
DDE and preterm birth (3). More contemporary studies
with fewer participants and lower DDE concentrations have
had conﬂicting results: Some (4–6), but not all (7–9), showed
associations between DDE exposure and adverse outcomes.
Several of these studies investigated a number of other organ-
ochlorines simultaneously. Increased risks of preterm birth
associated with hexachlorobenzene levels have been de-
scribed in 2 studies (8, 10), and associations with hexachlor-
ocyclohexane (mainly the β isomer) were described in 2
others (4, 8).
Chlordecone (kepone) is an organochlorine insecticide
principally used for control of the banana root borer in Cen-
tral and South America and the Caribbean, including Puerto
Rico (11). It was initially manufactured in the United States,
but production and use were banned there in 1976. Subse-
quently, it was produced in Brazil and intensively used in
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banana ﬁelds in the French West Indies from 1981 to 1993. It
is highly persistent in the environment; there is no signiﬁcant
biotic or abiotic degradation. Some soils in current and pre-
vious bananaﬁelds and somewaterways are permanently pol-
luted (12, 13). Currently, human exposure to chlordecone in
the French West Indies results mainly from the consumption
of contaminated food, especially seafood, root vegetables,
and cucurbitaceae, as assessed by studies in the general pop-
ulation (14) and among pregnant women (15).
The toxicity of chlordecone to humans was discovered in
1975 after a poisoning episode in pesticide plant workers in
the industrial city of Hopewell, Virginia. Male workers
showed evidence of sustained toxicity involving the nervous
system, liver, and testes (16–18). Additional studies on ani-
mals revealed that pregestational or gestational exposure of
rats and mice to chlordecone affected embryo implantation
and both prenatal and postnatal development (19). The mech-
anism of the toxic action of chlordecone is not completely
understood. It has been suggested that its hormonal proper-
ties may be involved. Chlordecone is an endocrine disruptor
with estrogen-like and progestin-like characteristics both in
vitro and in vivo (20–24).
Experimental studies have documented the toxic effects of
chlordecone exposure during gestation in animals, but there has
been no epidemiologic study to determinewhether chlordecone
has similar consequences in humans at environmentally
relevant exposure levels. The Timoun Mother–Child Cohort
Study was established to investigate the impact on pregnancy
and child development of prenatal exposure to the widespread
chlordeconepollution in theFrenchWest Indies.Here,we report
the relationships betweenmaternal exposure to chlordecone and
both the length of gestation and the risk of preterm birth.
METHODS
Study population
The present study was conducted in Guadeloupe (part of
the French West Indies), an archipelago situated in the Carib-
bean Sea with a population of 450,000 inhabitants who are
mostly of African descent. From December 2004 to Decem-
ber 2007, there were 1,068 women enrolled in a prospective
epidemiologic mother-child cohort study. Women were en-
rolled during third-trimester check-up visits at public health
centers (University Hospital of Pointe-à-Pitre, General Hos-
pital of Basse-Terre, and antenatal care units). To be eligible,
participants had to have resided in Guadeloupe for more than
3 years. The proportion of refusal was approximately 7%, and
the most common reasons were refusal of the spouse, not
wishing to participate in the follow-up, and not wishing to
provide biological samples. The study was approved by the
Guadeloupean Ethics Committee for studies involving
human subjects, and detailed informed consent was obtained
from each woman.
At enrollment, the participants answered a standardized
questionnaire during a face-to-face interviews with trained
midwives. The questionnaire covered sociodemographic
characteristics, medical and obstetrical history, and lifestyle
factors. Alcohol consumption during pregnancy was ascer-
tained on 2 occasions: during the interview at enrollment
and after delivery. After delivery, the medical history of the
pregnancy and delivery information were collected frommid-
wives, pediatricians, and hospital medical records. Cases in-
volving multiple births (n = 29), terminations of pregnancy
for fetal abnormality (n = 2), and stillbirths (n = 4) were ex-
cluded, resulting in a study sample of 1,033 singleton live
births. From these eligible cases, maternal blood samples
were obtained at delivery for 818 women.
Outcomes
Gestational age in weeks was estimated by the obstetri-
cians in charge of follow-up. It was based on the ﬁrst day
of the last menstrual period and was conﬁrmed or corrected
by ultrasound. Data were available for 97% of the pregnan-
cies. Preterm birth was deﬁned as a birth before 37 completed
weeks of gestation (25). We distinguished between spontane-
ous and medically induced births. Induced births included all
cases of induced labor and of caesarean delivery before the
onset of labor. Elective induced labor was not practiced at
the delivery centers involved in this study.
Exposure assessment
Maternal blood samples were collected into spray-coated
dipotassium ethylenediaminetetraacetic acid tubes. After
centrifugation, plasma samples were stored at −20°C. Sam-
ples were identiﬁed using only a sample code. They were
transferred by airmail on dry ice to Liege, Belgium, for or-
ganochlorine and lipid analysis.
Determination of chlordecone was done by the Center for
Analytical and Research Technology at Liege University in
Belgium. The preparation of samples and the quantiﬁcation
method have been previously described (26–28). Details are
provided in Web Appendix 1, available at http://aje.oxford
journals.org/. The limit of detection (LOD) was set at 3 times
the background noise of the chromatogram and was thus
0.06 μg/L. Samples from a subgroup of 358 women who de-
livered after 37 weeks of gestation and whose children were
enrolled for neurodevelopmental follow-up were also assayed
to assess DDE and polychlorinated biphenyl 153 levels (26).
The LODs for both compounds were 0.05 μg/L. Total choles-
terol and triglyceride concentrations in plasmawere determined
using standard enzymatic procedures (DiaSys Diagnostic Sys-
tems GmbH, Holzheim, Germany), and total lipid concentra-
tions were calculated as described previously (29).
Data and statistical analysis
Exposure was deﬁned according to the chlordecone con-
centration in maternal plasma (modeled on a wet-weight
basis) and was categorized in quintiles. A decimal log-
transformed continuous exposure variablewas also used.Mul-
tiple imputations were implemented to impute chlordecone
concentrations below the LOD. The likelihood method was
used (30) under the assumption that chlordecone is log-
normally distributed. Five data sets with imputed concentra-
tions below the LODwere generated.Modeling of associations
with the length of gestation and the risk of preterm birth was
performed within each set, and the results were combined
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using the Proc MIANALYZE procedure in SAS (SAS Insti-
tute, Inc., Cary, North Carolina) according to the methodol-
ogy described by Rubin (31) and Little and Rubin (32).
Because the LODwas below the ﬁrst quintile of the distribution,
the multiple imputation exclusively applied to analyses based
on the chlordecone concentration as a continuous predictor.
We collected information on socioeconomic and lifestyle
characteristics, including maternal place of birth (French
West Indies, other Caribbean islands, or Europe), enrollment
site (university hospital (Pointe à Pitre), local hospital
(Basse-Terre), or antenatal care units), age (<20, 20–24,
25–29, 30–34, or ≥35 years), years of education (<5, 5–12,
or >12 years), smoking during pregnancy (yes or no), and al-
cohol consumption during pregnancy (yes, deﬁned as at least
1 drink during preceding week or 1 binge drinking session
during the previous 3 months reported at enrollment or
after delivery, or no). We also collected information on mar-
ital status, which we then classiﬁed into 3 categories corre-
sponding to family proﬁles common in the French West
Indies: single, living with a partner, and single but living
with family (an adult member of her family, typically mother,
father, sister, or aunt). Medical and reproductive factors re-
corded included parity (deﬁned as the number of previous vi-
able pregnancies: 0, 1, or ≥2), number of prior preterm births
Table 1. Characteristics of Study Participants (n = 818), Length of Gestation, and Rate of Preterm Births (n = 115),
Timoun Mother–Child Cohort Study, Guadeloupe, French West Indies, 2004–2007
Births Length of Gestation,weeks Rate of Preterm Birth
a
No. % Mean (SD) P Valueb % P Valuec
Maternal age, years 0.01 0.25
<20 62 7.6 38.5 (1.4) 11.3
20–24 118 14.4 38.5 (1.7) 14.4
25–29 161 19.7 38.4 (1.8) 10.6
30–34 214 26.2 38.4 (1.8) 13.5
≥35 263 32.2 37.9 (2.0) 17.1
Maternal place of birth 0.05 0.24
French West Indiesd 634 77.5 38.2 (1.9) 15.0
Other Caribbean Islands 90 11.0 38.4 (1.4) 11.1
Europe 94 11.5 38.6 (1.7) 10.6
Parity 0.10 0.76
0 301 36.8 38.4 (1.7) 13.0
1 252 30.8 38.3 (1.9) 14.3
≥2 265 32.4 38.1 (1.9) 15.1
Marital status 0.09 0.12
Single 206 25.9 38.1 (2.0) 16.0
Married or in a couple 429 53.8 38.4 (1.7) 11.7
Living with own family 162 20.3 38.2 (1.9) 16.7
Maternal education, years 0.69 0.96
<5 47 5.7 38.0 (1.7) 14.9
5–12 573 70.1 38.3 (1.9) 13.8
>12 198 24.2 38.3 (1.6) 14.7
Body mass indexe 0.02 0.20
<18.5 54 6.7 38.1 (1.4) 11.1
18.5–24.9 421 52.5 38.5 (1.6) 11.6
25–29.9 180 22.4 38.0 (2.2) 17.8
≥30 147 18.3 38.2 (2.0) 15.7
Smoking during pregnancy 0.23 0.25
Yes 47 5.8 38.6 (1.5) 10.6
No 771 94.2 38.2 (1.8) 14.3
Alcohol during pregnancy 0.37 0.88
Yes 23 2.9 38.6 (1.6) 13.0
No 760 97.1 38.3 (1.7) 13.8
Table continues
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(0, 1, or ≥2), number of prior miscarriages (0, 1, or ≥2), tim-
ing of ﬁrst ultrasound (before 15 weeks of gestation or at 15
weeks or more), sex of the newborn (male or female), self-
reported body mass index (weight (kg)/height (m)2) before
pregnancy, and presence of maternal disease (particularly
high blood pressure) during pregnancy, including preeclamp-
sia (yes or no), gestational diabetes (yes or no), urinary tract
infection during pregnancy (yes or no), and asthma (yes or
no). Body mass index was classiﬁed into 4 groups: under-
weight (<18.5), normal weight (18.5–24.9), overweight
(25–29.9), and obese (≥30). The rates of missing data for
covariates varied from none to 2.6%.
Linear regression models were used to evaluate the rela-
tionship between chlordecone exposure and the length of
gestation. The regression coefﬁcient (β) represented a diffe-
rence of 1 week in the length of gestation per chlordecone ex-
posure category or per decimal log unit of the transformed
plasma chlordecone concentration. To describe the shape of
the dose-response relationship, we examined splines (re-
stricted cubic spline functions with 3 knots at the quartiles
of the distribution) using the SAS macro developed by
Desquilbet and Mariotti (33). This approach allowed identi-
ﬁcation of the linear and/or nonlinear components of the re-
lationship. Associations between maternal exposure and the
risk of preterm birth were estimated by calculating a hazard
ratio using a Cox model that accounted for the left truncation
that is a possible consequence of inclusion of participants
during late pregnancy (34).
Table 1. Continued
Births Length of Gestation,weeks Rate of Preterm Birth
a
No. % Mean (SD) P Valueb % P Valuec
Timing of first ultrasound 0.38 0.77
<15 gestational weeks 675 84.7 38.2 (1.8) 13.9
≥15 gestational weeks 122 15.3 38.4 (2.0) 14.8
High blood pressure during pregnancy <0.001 <0.001
Yes 99 12.3 37.1 (2.4) 35.4
No 705 87.7 38.4 (1.7) 11.1
Gestational diabetes 0.003 0.06
Yes 74 9.3 37.7 (2.0) 18.9
No 725 90.7 38.3 (1.8) 13.2
Urinary tract infection 0.05 0.02
Yes 123 15.6 38.0 (1.9) 20.3
No 667 84.4 38.3 (1.8) 12.4
Prior preterm birth 0.01 0.04
Yes 80 9.9 37.7 (1.6) 22.5
No 725 90.1 38.3 (1.8) 13.4
Prior miscarriage 0.0001 0.02
Yes 212 25.9 37.8 (1.9) 19.3
No 605 74.1 38.4 (1.8) 12.2
Asthma 0.56 0.13
Yes 83 10.2 38.2 (1.9) 19.3
No 732 89.8 38.3 (1.8) 13.5
Enrollment site 0.06 0.07
University hospital 558 68.2 38.2 (1.9) 15.6
Local hospital 186 22.7 38.5 (1.6) 9.7
Local antenatal care clinic 74 9.1 38.3 (1.4) 13.5
Sex of the newborn
Female 404 49.4 38.4 (1.8) 0.05 12.4 0.20
Male 414 50.6 38.1 (1.9) 15.7
Abbreviation: SD, standard deviation.
a Birth before 37 complete weeks of gestation.
b Two-sided P value for differences between means (t test).
c Two-sided P value for differences between rates (χ2 test).
d Guadeloupe and Martinique.
e Weight (kg)/height (m)2.
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Although many risk factors for preterm births have been
clearly established, the potential link between chlordecone
exposure and these risk factors has not been thoroughly stud-
ied; this is due in part to the very small number of studies
of this exposure in humans. Using current knowledge on
preterm birth risk factors and the relationship between
chlordecone exposure and these factors (Web Table 1), we
constructed a directed acyclic graph for preterm birth (Web
Figure 1). History of preterm births was not considered as
a confounder because it reﬂects an unmeasured degree of vul-
nerability and simultaneously may be a consequence of pre-
vious exposure (if any association exists); therefore, it appears
as a collider. Our data provided no evidence of an association
between parity and levels of chlordecone (Web Table 1). This
is consistent with the pharmacokinetics of chlordecone: Un-
like most other organochlorines, chlordecone is not signiﬁ-
cantly stored in fat tissues, and plasma levels are therefore
not signiﬁcantly affected by the lipid tissue redistribution
that occurs during pregnancy and breastfeeding. The mini-
mally sufﬁcient set of adjustment variables based on the pro-
posed directed acyclic graph included maternal enrollment
site, place of birth, marital status, educational level, age,
body mass index before pregnancy, and high blood pressure
during pregnancy. We conducted sensitivity analyses that in-
cluded additional adjustment of parity and analyses that
included adjustment for gestational diabetes, as well as anal-
yses in which we excluded blood pressure.
In the subgroup of 358 women in whom DDE and poly-
chlorinated biphenyl 153 were measured, the Spearman’s
rank correlations coefﬁcient between chlordecone and DDE
was 0.017 (P = 0.75), and that between chlordecone and
polychlorinated biphenyl 153 was −0.016 (P = 0.76). There-
fore, DDE and polychlorinated biphenyl 153 were not con-
sidered to be confounders.
Lipophilic molecule concentrations are routinely ex-
pressed on a per-unit serum lipid basis, but this approach is
prone to bias (35). Furthermore, a substantial portion of the
chlordecone in blood is associated with proteins (mainly
albumin) and high-density lipoproteins (36), whereas most
other organochlorine compounds are associated with
low-density lipoproteins and very high-density lipoproteins;
consequently, expressing the chlordecone concentration on a
per-unit serum lipid basis may be misleading. Nevertheless,
to account for the residual chlordecone fraction transported
by lipids, we considered total lipids in the adjusted models.
We also considered a possible interaction between
chlordecone exposure and the sex of the newborn in relation
to length of gestation and the risk of preterm birth. All statis-
tical analyses were performed using SAS, version 9.3.
RESULTS
Most of the women in our study were born on Caribbean
islands (primarily the French West Indies) where most inhab-
itants are of African descent, and most were multiparous
(Table 1). Approximately two thirds were enrolled into the
study at the University Hospital, and approximately two ﬁfths
were overweight or obese before pregnancy. Very few women
reported smoking (5.8%) or alcohol consumption (2.9%) dur-
ing pregnancy. The mean duration of gestation was 38.3
weeks, and 14.1% of the children (n = 115) were born preterm.
Among the preterm births, 55 (47.8%) were spontaneous pre-
term births and 59 (51.3%) were medically induced preterm
births; for 1 woman, the type of preterm birth could not be
traced. Gestational age at enrollment (mean, 27.2 weeks) did
not differ between spontaneous and induced preterm births
and term births. Rates of detection and concentrations of or-
ganochlorine compounds in the plasma of a subsample of
the study population are presented in Table 2.
We studied the shape of the dose-response relationship
using splines. It appeared that the shape of the curve presented
a signiﬁcant decreasing linear component (P = 0.03), with
the nonlinear component not being signiﬁcant (P = 0.39)
(Web Figure 2).
Table 3 shows the results of linear regression analysis for
maternal chlordecone levels in relation to length of gestation. In
the adjusted model, there was a statistically signiﬁcant shorter
length of gestation in the 2 highest quintiles of exposure. When
studying exposure as a continuous variable, we found that high-
er maternal chlordecone levels were statistically signiﬁcantly
associated with a shorter length of gestation in adjustedmodels.
Table 2. Detection and Concentration of Organochlorine Compounds in Maternal Plasma Among Timoun Mother–
Child Cohort Study Participants, Guadeloupe, French West Indies, 2004–2007
Type of
Organochlorine
by Group
No. of
Births
Detection
Frequency,
%
Geometric
Mean,
μg/L
Minimum,
μg/L
Percentile, μg/L Maximum,
μg/L5th 25th 50th 75th 95th
All women
Chlordecone 818 88.4 0.35 <LOD <LOD 0.18 0.39 0.83 2.50 19.7
Subgroupa
Chlordecone 358 92.2 0.34 <LOD <LOD 0.19 0.40 0.88 2.42 19.3
DDE 358 86.0 0.63 <LOD <LOD 0.22 0.59 1.26 4.10 24.5
PCB 153 358 87.7 0.18 <LOD <LOD 0.09 0.18 0.34 0.94 1.95
Abbreviations: DDE, p,p0-dichlorodiphenyl dichloroethene; LOD, limit of detection; PCB 153, polychlorinated
biphenyl 153.
a Subgroup of 358 women who delivered after 37 weeks of gestation and whose children were enrolled for
neurodevelopmental follow-up.
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When all births were considered, the adjusted hazard ratio
of preterm birth appeared to be statistically signiﬁcantly in-
creased for the fourth (hazard ratio = 3.1, 95% conﬁdence in-
terval: 1.6, 6.0) and ﬁfth (hazard ratio = 2.2, 95% conﬁdence
interval: 1.1, 4.5) quintiles (Table 4). Expressing exposure as
a continuous variable led to maternal chlordecone levels
being statistically signiﬁcantly associated with a higher haz-
ard ratio for preterm birth in the adjusted model. Similar as-
sociations were observed when the analyses were done
according to the mode of onset of labor (Table 4).
The ﬁndings remained unchanged when parity or gesta-
tional diabetes was included in the full model (Web Table 2).
However, the strength of the associations decreased when
high blood pressure was excluded from the model (Web
Table 2). Women with high blood pressure during pregnancy
appeared to have lower chlordecone blood concentrations
than did other women (Web Table 1).
Women for whomwewere not able tomeasure chlordecone
concentration (n = 215) were more often recruited in the local
hospital of Basse-Terre, which is in the most contaminated
area in Guadeloupe. They tended to have shorter lengths of
gestation (38.0 weeks vs. 38.3 weeks; P = 0.04) and a higher
prevalence of preterm births (19.1% vs. 14.1%; P = 0.07)
than did women for whom blood samples were available.
Sensitivity analyses imputing expected median values of
chlordecone according to major determinants of chlordecone
exposure had only small impact on risk estimates (Web
Table 3). Despite the interaction between chlordecone expo-
sure and the sex of the newborn not being statistically signiﬁ-
cant (P > 0.2) in relation to length of gestation and the risk of
preterm birth, the stratiﬁed results suggest a higher level of
association among girls than boys (Web Table 4).
DISCUSSION
We examined the association between levels of chlordecone
in maternal plasma and the duration of pregnancy in a popu-
lation of pregnant women in Guadeloupe. We observed that
greater maternal exposure to chlordecone was associated
with shorter gestation. In addition, higher levels of exposure
were associated with an increased risk of preterm birth in a
dose-response–type association for all preterm births and
for all modes of labor.
The present epidemiologic study is one of the few in which
the association between chlordecone at environmentally rel-
evant exposure levels and human health was examined (27,
37, 38). Local soil pollution by chlordecone (20% of agricul-
tural lands) caused by its use in banana plantations between
1973 and 1993 has led to the contamination of root and cu-
curbit vegetables and of livestock and poultry that graze
on these contaminated areas; costal ﬁsh and seafood are
also contaminated. These contaminated foodstuffs represent
only a fraction of what is consumed in the French West In-
dies, but they explain the chronic contamination of the pop-
ulation. Regulatory measures to restrict commercialization of
those food products that exceed threshold limit values of con-
tamination have been implemented to reduce human expo-
sure, but these measures only apply to licensed farms and
ﬁshermen. Indeed, there is an extensive informal network of
production, distribution, and sale of foodstuffs, as well as fam-
ilies and individuals who produce food for their own consump-
tion. These chains of supply are not adequately controlled.
Chlordecone has not been measured in populations other
than those in the French West Indies (27, 37, 38) and Hope-
well, Virginia (16, 17). The poisoning episode that affected
pesticide plant workers in Hopewell (most of whom were
men) during the mid-1970s led to a very high exposure
rate, resulting in blood concentrations 100 to 1,000 times
greater than those currently observed in the population of
the FrenchWest Indies. Chlordecone exposure was also mea-
sured in adult Hopewell residents during the mid-1970s, and
the serum concentrations in subjects with detectable values
(at that time the LOD was around 1.5 μg/L) was between
5–32 μg/L (16), a range similar to those currently observed
in the population of the French West Indies.
The strengths of the present study include its prospective
design, the evaluation of exposure based on determinations
of the chlordecone concentration in maternal plasma, and
the consideration of co-exposures to other organochlorine
compounds (DDE and polychlorinated biphenyl 153). Single
Table 3. Crude and Adjusted Regression Coefficients for Length of Gestation According to Chlordecone
Concentration in Maternal Blood Among Timoun Mother–Child Cohort Study Participants, Guadeloupe, French West
Indies, 2004–2007
Chlordecone Level,
μg/L
No. of
Births
Crude Adjusteda
β 95% CI β 95% CI
<0.14 163 0.0 Referent 0.00 Referent
0.14–0.28 165 −0.10 −0.50, 0.30 −0.26 −0.66, 0.13
0.29–0.51 162 −0.10 −0.50, 0.30 −0.23 −0.62, 0.16
0.52–0.97 165 −0.31 −0.71, 0.30 −0.60 −0.99, −0.20
>0.98 163 −0.25 −0.65, 0.15 −0.48 −0.88, −0.07
Log10 chlordecone 818 −0.11 −0.34, 0.11 −0.27 −0.50, −0.03
Abbreviation: CI, confidence interval.
a The covariates for which we adjusted werematernal age, place of birth, enrollment site, marital status, educational
level, body mass index, high blood pressure during pregnancy, and total plasma lipid level (g/L). The analysis was
conducted on 767 complete cases.
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determinations of plasma chlordecone concentration provide
an accurate reﬂection of the load of this compound in the
body (17, 39). Its half-life in blood is approximately 6
months (17), so a single measure at the end of pregnancy
can be considered to be reasonably representative of exposure
throughout the pregnancy.
Our study also has some limitations. The prevalence of
preterm birth in our study population was 14.1%, consistent
with the high rate of preterm births among populations of Af-
rican descent irrespective of their geographic location (40,
41). Nevertheless, we may have overestimated this rate be-
cause recruitment was mainly at the University Hospital,
and this favors inclusion of pregnant women at risk of pre-
term birth. This also explains the high proportion of induced
preterm births compared with spontaneous preterm births.
However, any such oversampling should not impair internal
comparisons. Also, the models for linear and logistic regres-
sion were adjusted for site of enrollment. There were small
differences in some population descriptors between the sub-
groups with and without plasma chlordecone determinations,
but sensitivity analyses indicated that these missing data were
only weakly associated with risk (Web Table 3). In our study
population, high blood pressure during pregnancy is associ-
ated with lower chlordecone blood concentrations, and we
have no immediate explanation for this ﬁnding. The mecha-
nisms through which chlordecone may lower the risk of high
blood pressure during pregnancy, the possible inﬂuence of
high blood pressure on chlordecone concentration in blood,
or the inﬂuence of unknown confounders in this association
remain to be studied. Inclusion of high blood pressure during
pregnancy as a variable in the adjusted model reinforces the
association between chlordecone exposure and risk of pre-
term birth.
We are aware that estimates of gestational age based on
ﬁrst trimester ultrasound may be biased if environmental ex-
posure affects early fetal growth (42), although in practice the
consequences of this problem are generally limited (43).
Moreover, toxicological studies in rats and mice have indicated
that chlordecone exposure during gestation, at doses that do
not cause maternal toxicity, was not associated with low fetal
growth (44).
Parturition is triggered by the shortening and dilatation of
the cervix associated with uterine contractions. Progesterone
plays a key role in maintaining pregnancy. In humans,
Table 4. Crude and Adjusted Hazard Ratios for Risk of Preterm Birth According to Chlordecone Concentration in
Maternal Blood and Mode of Onset of Labor, Timoun Mother–Child Cohort Study, Guadeloupe, French West Indies,
2004–2007
Chlordecone Level by Birth
Category, μg/L
No. of
Births
No. of
PTBb
Crude Adjusteda
HR 95% CI HR 95% CI
All births
<0.14 163 16 1.0 Referent 1.0 Referent
0.14–0.28 165 21 1.5 0.8, 2.8 1.5 0.7, 3.1
0.29–0.51 162 23 1.6 0.8, 3.0 1.6 0.8, 3.1
0.52–0.97 165 30 2.1 1.1, 4.0 3.1 1.6, 6.0
>0.98 163 25 1.7 0.9, 3.3 2.2 1.1, 4.5
Log10 chlordecone 818 115 1.3 0.9, 1.9 1.6 1.1, 2.3
Spontaneous preterm and term births
<0.14 154 7 1.0 Referent 1.0 Referent
0.14–0.28 151 10 1.5 0.6, 4.1 1.4 0.5, 4.0
0.29–0.51 145 6 1.0 0.3, 2.9 1.1 0.3, 3.5
0.52–0.97 154 16 2.6 1.1, 6.6 3.5 1.3, 9.8
>0.98 154 16 2.6 1.1, 6.6 2.7 0.9, 7.8
Log10 chlordecone 758 55 1.7 1.1, 2.8 1.8 1.0, 3.3
Induced preterm and term births
<0.14 147 8 1.0 Referent 1.0 Referent
0.14–0.28 149 11 1.7 0.7, 4.3 2.2 0.7, 6.2
0.29–0.51 156 17 2.3 1.0, 5.6 2.6 1.0, 6.5
0.52–0.97 155 14 2.1 0.9, 5.2 3.3 1.3, 8.7
>0.98 155 9 1.3 0.5, 3.6 2.2 0.8, 6.4
Log10 chlordecone 762 59 1.1 0.7, 1.8 1.5 0.9, 2.6
Abbreviations: CI, confidence interval; HR, hazard ratio; PTB, preterm birth.
a The covariates for whichwe adjusted werematernal age, place of birth, enrollment site, marital status, educational
level, body mass index, high blood pressure during pregnancy, and total plasma lipid level (g/L). The analysis was
conducted on 750 complete cases for all births, 694 spontaneous preterm births, and 703 induced preterm births.
b For one woman, the type of preterm birth was unknown.
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progesterone-receptor–dependent events, rather than circulat-
ing progesterone levels, appear to be critical (45). For exam-
ple, treatment of pregnant women with progesterone-receptor
antagonists induces labor at any stage of pregnancy (46).
Chlordecone binds estrogen receptors α and β, acting as an
agonist of estrogen receptor α and an antagonist of estrogen
receptor β (47, 48). It also stimulates the synthesis of the pro-
gesterone receptors in rat uterine tissues in vivo (21), and this
process is mediated by estrogen receptors. Chlordecone can
inhibit the binding of the progestin agonist R5020 to the form
A of the progesterone receptor in vitro (22). These observa-
tions suggest that the observed associations between expo-
sure to chlordecone and both decreased gestational length
and increased risk of preterm birth are due to the estrogenic
and/or progestin activities of chlordecone.
In summary, the data that we report provide some evidence
that chlordecone, a chemical with well-established estrogen-
like and progestin-like properties, may affect the duration of
gestation (with gestation at least 3 days shorter for the 40% of
women with blood chlordecone levels >0.52 μg/L) and thus
increase the risk of preterm birth. These ﬁndings were ob-
served in a population with a high baseline risk of preterm
birth. The association was detectable even though the con-
centrations of chlordecone in the blood were in the order of
magnitude of 1 part per billion. Further efforts are required to
protect pregnant women against exposure to chlordecone,
particularly from its major dietary sources.
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